Autor:
Cabrera, D.
Gutiérrez, J.
Cabello-Verrugio, C.
Morales, M. G.
Mezzano, S.
Fadic, R.
Casar, J. C.
Hancke, J. L.
Brandan, E.
Background: Duchenne muscular dystrophy (DMD) is characterized by the absence of the cytoskeletal protein dystrophin, muscle wasting, increased transforming growth factor type beta (TGF-β) signaling, and fibrosis. At the present time, the only clinically validated treatments for DMD are glucocort...
Enlace original:
https://repositorio.uc.cl/handle/11534/27461https://repositorio.uc.cl/handle/11534/27461
Cabrera, D.
,
Gutiérrez, J.
,
Cabello-Verrugio, C.
,
Morales, M. G.
,
Mezzano, S.
,
Fadic, R.
,
Casar, J. C.
,
Hancke, J. L.
,
Brandan, E.
,
[Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis]
,
Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis
